<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Dev Biol</journal-id><journal-title>BMC Developmental Biology</journal-title><issn pub-type="epub">1471-213X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-213X-8-103</article-id><article-id pub-id-type="pmid">18950487</article-id><article-id pub-id-type="doi">10.1186/1471-213X-8-103</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Domain-specific regulation of <italic>foxP2 </italic>CNS expression by <italic>lef1</italic></article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Bonkowsky</surname><given-names>Joshua L</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>joshua.bonkowsky@hsc.utah.edu</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Wang</surname><given-names>Xu</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>xu.wang@neuro.utah.edu</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Fujimoto</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>fujimoto@neuro.utah.edu</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Lee</surname><given-names>Ji Eun</given-names></name><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><email>j11lee@ucsd.edu</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Chien</surname><given-names>Chi-Bin</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>chi-bin.chien@neuro.utah.edu</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Dorsky</surname><given-names>Richard I</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>richard.dorsky@neuro.utah.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Pediatric Neurology, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah 84108, USA</aff><aff id="I2"><label>2</label>Department of Neurobiology and Anatomy, University of Utah School of Medicine, Salt Lake City, Utah 84132, USA</aff><aff id="I3"><label>3</label>Neurogenetics Laboratory, Department of Neurosciences, University of California, San Diego, La Jolla, California 92093, USA</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>24</day><month>10</month><year>2008</year></pub-date><volume>8</volume><fpage>103</fpage><lpage>103</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-213X/8/103"/><history><date date-type="received"><day>7</day><month>8</month><year>2008</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Bonkowsky et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Bonkowsky et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Bonkowsky L Joshua joshua.bonkowsky@hsc.utah.edu </dc:author><dc:title> Domain-specific regulation of foxP2 CNS expression by lef1 </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Developmental Biology 8(1): 103-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-213X(2008)8:1&#x0003c;103&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-213X</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p><italic>FOXP2 </italic>is a forkhead transcription factor critical for normal development of language in humans, but little is known of its broader function and regulation during central nervous system (CNS) development. We report here that <italic>lef1</italic>, a member of the Lef/Tcf family of transcription factors activated by Wnt signaling, regulates <italic>foxP2 </italic>during embryogenesis, and we isolate novel <italic>foxP2 </italic>enhancers which are <italic>lef1</italic>-dependent.</p></sec><sec><title>Results</title><p>Loss, knock down, or inhibition of <italic>lef1 </italic>led to loss of <italic>foxP2 </italic>expression. We isolated DNA fragments from the <italic>foxP2 </italic>genomic region that function as enhancers to drive GFP expression in the CNS during development, including in the telencephalon, diencephalon, eye, tectum, and hindbrain. Three of these enhancers, foxP2-enhancerA.1, foxP2-enhancerB, and foxP2-enhancerD, contain putative Lef1 binding sites, and are regulated by <italic>lef1</italic>. However, two other genomic fragments containing Lef1 sites failed to function <italic>in vivo </italic>as enhancers. Chromatin immunoprecipitation confirmed that Lef1 binds to sites in foxP2-enhancerA.1 and foxP2-enhancerB.</p></sec><sec><title>Conclusion</title><p>This work shows that <italic>lef1 </italic>is necessary for expression of <italic>foxP2 </italic>in the tectum, mid-hindbrain boundary, and hindbrain during CNS development, and is the first insight into the upstream regulation of <italic>foxP2 </italic>during development. We also demonstrate that <italic>in silico </italic>prediction of potential <italic>lef1 </italic>binding sites poorly predicts their ability to function <italic>in vivo </italic>as enhancers. The <italic>foxP2 </italic>enhancers we identified will allow dissection of <italic>foxP2</italic>'s role during CNS development.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p><italic>FOXP2 </italic>is a forkhead domain transcription factor whose mutation has been associated with severe deficits in language [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Its cloning and expression during development have been described in humans, mouse, songbird, frog, medaka, and zebrafish [<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B16">16</xref>]. CNS expression during development in the different vertebrate species is remarkably similar, with conserved expression in the telencephalon, basal ganglia, thalamus, tectum, tegmentum, cerebellum, and hindbrain. However, the function of <italic>FOXP2 </italic>during CNS development is poorly understood. Homozygous knockout or point mutation of Foxp2 in mice leads to early postnatal death, with reports of disordered Purkinje cell layers [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>] and smaller cerebellar size [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. In songbirds, <italic>FoxP2 </italic>appears to be necessary for vocal learning and is expressed in neurons during active song learning [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>The neural circuits and genetic cascades in which <italic>FOXP2 </italic>participates remain uncharacterized. Chromatin immunoprecipitation methods have identified potential downstream targets of <italic>FOXP2 </italic>[<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>], but <italic>in vivo </italic>function and importance of the identified targets is uncertain. To understand in greater detail the role of <italic>foxP2 </italic>in CNS development, we sought to identify how <italic>foxP2 </italic>expression is regulated. The conservation of six predicted <italic>lef1 </italic>binding sites between pufferfish, zebrafish, mouse, and human in the <italic>foxP2 </italic>genomic region (this study; [<xref ref-type="bibr" rid="B25">25</xref>], and the overlapping expression of <italic>lef1 </italic>and <italic>foxP2 </italic>in the zebrafish CNS during development, led us to consider whether <italic>lef1 </italic>might regulate <italic>foxP2</italic>. Lef1 is a transcription factor activated by the canonical Wnt/&#x003b2;-catenin signaling pathway, which has been shown to play a critical role in proliferation, tissue patterning, CNS neuronal cell fate specification, and axon pathfinding [<xref ref-type="bibr" rid="B26">26</xref>]. We found that loss or knockdown of <italic>lef1 </italic>led to a loss of <italic>foxP2 </italic>expression in the tectum, mid-hindbrain boundary, and hindbrain. Of six conserved potential <italic>lef1 </italic>binding sites predicted in the <italic>foxP2 </italic>genomic region [<xref ref-type="bibr" rid="B25">25</xref>], we show that only three lie in genomic fragments that function <italic>in vivo </italic>as enhancers, underscoring the importance of <italic>in vivo </italic>testing of predicted enhancers. Using chromatin immunoprecipitation (ChIP), we demonstrated that <italic>lef1 </italic>can bind directly to the functional enhancer sites, and showed that in the absence of <italic>lef1 </italic>these enhancers fail to function. The <italic>foxP2 </italic>enhancers will be useful for dissection of <italic>foxP2 </italic>function by allowing detailed analysis of axon pathfinding and synaptogenesis in <italic>foxP2</italic>-expressing neurons.</p></sec><sec><title>Results</title><sec><title><italic>foxP2 </italic>and <italic>lef1 </italic>have sequential and overlapping expression in the CNS during embryogenesis</title><p>We noted that 6 binding sites for Tcf/Lef transcription factors are conserved between mouse and pufferfish in the <italic>FOXP2 </italic>genomic region, which is more than for any other putative Tcf/Lef target gene (Table S6 of [<xref ref-type="bibr" rid="B25">25</xref>]. This finding, and our prior observations that <italic>foxP2 </italic>and <italic>lef1 </italic>are expressed in the tectum and hindbrain during CNS embryogenesis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B27">27</xref>], raised the possibility that <italic>lef1 </italic>might regulate <italic>foxP2 </italic>expression. We performed <italic>in situ </italic>labeling for <italic>foxP2 </italic>and <italic>lef1 </italic>to investigate whether they shared temporal and/or spatial domains of expression. We found that <italic>lef1 </italic>is expressed in the mid-hindbrain boundary (MHB) starting at 24 hpf, and in the tectum starting at 30 hpf (Figure <xref ref-type="fig" rid="F1">1A&#x02013;C</xref>). <italic>foxP2 </italic>expression in the MHB and tectum becomes apparent at 36 hpf (Figure <xref ref-type="fig" rid="F1">1D&#x02013;F</xref>). Other domains of <italic>lef1 </italic>and <italic>foxP2 </italic>expression, including the telencephalon, hypothalamus, and dorsal diencephalon, had non-overlapping expression. To confirm that <italic>foxP2 </italic>and <italic>lef1 </italic>are indeed co-expressed in the same cells, rather than in distinct subsets of cells in the same region, we performed double <italic>in situs</italic>, and found that <italic>foxP2 </italic>and <italic>lef1 </italic>are co-expressed in tectal cells at 36 hpf (Figure <xref ref-type="fig" rid="F2">2A&#x02013;D</xref>). This sequentially overlapping pattern of expression in the MHB, and contemporaneous overlap in the tectum, confirmed that <italic>lef1 </italic>was present in a relevant pattern to potentially direct <italic>foxP2 </italic>expression.</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Sequential expression of <italic>foxP2 </italic>and <italic>lef1 </italic>in the CNS during embryogenesis</bold>. Whole-mount <italic>in situs </italic>for <italic>lef1 </italic>(A-C) and <italic>foxP2 </italic>(D-F) at 24 hpf, 30 hpf, and 36 hpf. Lateral views, anterior to left, dorsal up; eyes have been removed to facilitate visualization. Scale bar = 50 &#x003bc;m. (Abbreviations: dd, dorsal diencephalon; hb, hindbrain; hy, hypothalamus; mhb, mid-hindbrain boundary; tec, tectum; tel, telencephalon.) (A-C): <italic>lef1 </italic>is expressed in the hypothalamus, dorsal midbrain, and MHB at 24 hpf, with expression extending to the tectum at 30 hpf. By 36 hpf expression is confined primarily to the hypothalamus and tectum. (D-F): <italic>foxP2 </italic>is expressed in the tectum and MHB starting at 36 hpf. Earlier expression (24 hpf and 30 hpf) is confined to the telencephalon.</p></caption><graphic xlink:href="1471-213X-8-103-1"/></fig><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Co-expression of <italic>foxP2 </italic>and <italic>lef1 </italic>in the tectum</bold>. Whole-mount double <italic>in situ </italic>confocal imaging for <italic>foxP2 </italic>and <italic>lef1 </italic>at 36 hpf, dorsal views, anterior up. Abbreviations: hb, hindbrain; tec, tectum; tel, telencephalon. (A) Z-stack projection of <italic>foxP2 </italic>(green) overlaid on brightfield image of <italic>lef1 </italic>expression in the tectum. The region shown in higher magnification in (B-D) is boxed in yellow. Scale bar = 50 &#x003bc;m. (B-D) Single optical plane showing <italic>lef1 </italic>(red- BM Purple), <italic>foxP2 </italic>(green- Alexa 488), and co-expression in the tectum. Arrow points to a representative co-expressing cell. Scale bar = 25 &#x003bc;m.</p></caption><graphic xlink:href="1471-213X-8-103-2"/></fig></sec><sec><title>Knockdown of <italic>lef1 </italic>causes loss of <italic>foxP2 </italic>expression</title><p>Based on this overlap of expression, we hypothesized that <italic>lef1 </italic>might regulate <italic>foxP2</italic>. To test this, we used several approaches. First, we used a morpholino to knockdown <italic>lef1 </italic>[<xref ref-type="bibr" rid="B27">27</xref>], and evaluated <italic>foxP2 in situ </italic>expression. Knockdown of <italic>lef1 </italic>causes a near-complete loss of <italic>foxP2 </italic>expression in the tectum, MHB, and hindbrain at 36 hpf (Figure <xref ref-type="fig" rid="F3">3A, B</xref>) in 85% of injected embryos (n = 61), compared with 0% of uninjected embryos (n = 53). This effect is specific to <italic>lef1</italic>, since a morpholino against a different Lef/Tcf family member, <italic>tcf3b </italic>[<xref ref-type="bibr" rid="B28">28</xref>], which is also expressed in the tectum and hindbrain [<xref ref-type="bibr" rid="B28">28</xref>], showed no effect on <italic>foxP2 </italic>expression (n = 48, data not shown). The loss of <italic>foxP2 </italic>expression in the hindbrain, where <italic>lef1 </italic>expression is not detectable by <italic>in situ </italic>(Figure <xref ref-type="fig" rid="F1">1A&#x02013;C</xref>), is presumably an indirect effect, perhaps via loss of an inductive signal from the MHB. Alternatively, this could be a direct effect, for example, if <italic>lef1 </italic>is expressed at very low levels in the hindbrain, or if some <italic>lef1</italic>-positive neurons migrate from the MHB to the hindbrain.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Loss of <italic>lef1 </italic>leads to absent <italic>foxP2 </italic>expression in the tectum, mid-hindbrain boundary, and hindbrain</bold>. Whole-mount <italic>in situ</italic>s at 36 hpf; anterior to left, dorsal up, eyes removed. Scale bar = 50 &#x003bc;m. (Conditions: hs:&#x00394;tcf, Tg<italic>(hsp70l:&#x00394;tcf-GFP</italic>)<sup>w26</sup>; <italic>lef1 </italic>mo, <italic>lef1 </italic>morphants; wt, wild type; x8, homozygous Df(<italic>LG01</italic>)<sup>x8</sup>. Abbreviations: hb, hindbrain; mhb, mid-hindbrain boundary; tec, tectum; tel, telencephalon.) (A, B) <italic>lef1 </italic>morphant (B) lacks expression in tectum, MHB, and hindbrain (<italic>arrows</italic>), compared to wild-type (A). (C) Df(<italic>LG01</italic>)<sup>x8 </sup>homozygote lacks expression in tectum, MHB, and hindbrain (<italic>arrows</italic>). (D) Tg<italic>(hsp70l:&#x00394;tcf:GFP</italic>)<sup>w26 </sup>embryo, three hours post-heat shock, lacks expression in tectum, MHB, and hindbrain (<italic>arrows</italic>). (E, F) <italic>mbx in situs</italic>; staining in tectum and hindbrain is indistinguishable between wild type and <italic>lef1 </italic>morphants (F).</p></caption><graphic xlink:href="1471-213X-8-103-3"/></fig><p>To confirm that loss of <italic>foxP2 </italic>expression was due to knockdown of <italic>lef1 </italic>and not a non-specific morpholino effect, we utilized two alternative means to remove <italic>lef1 </italic>expression. First, we examined expression of <italic>foxP2 </italic>in Df(<italic>LG01</italic>)<sup>x8 </sup>mutant embryos. Df(<italic>LG01</italic>)<sup>x8 </sup>is a deletion on chromosome 1 which contains <italic>lef1 </italic>(but not <italic>foxP2</italic>); homozygous deficiency mutants do not express <italic>lef1 </italic>[<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. We found that homozygous Df(<italic>LG01</italic>)<sup>x8 </sup>mutants do not express <italic>foxP2 </italic>in the tectum, MHB, or hindbrain (Figure <xref ref-type="fig" rid="F3">3C</xref>) (100%, n = 25 embryos).</p><p>Second, we examined whether a dominant negative construct which inhibits <italic>lef1 </italic>function would cause a loss of <italic>foxP2 </italic>expression. We used embryos carrying the transgene <italic>hsp70l:&#x00394;tcf-GFP</italic>, which expresses an N-terminal deletion of Tcf3a fused to GFP. In the absence of its N-terminal DNA-binding domain, Tcf3a acts as a dominant repressor of Wnt-mediated transcription [<xref ref-type="bibr" rid="B30">30</xref>]. Following heat-shock at 32 hpf for 1 hour, embryos were collected 3 hours post-heat shock. There was loss of <italic>foxP2 </italic>expression in the tectum, MHB, and hindbrain (Figure <xref ref-type="fig" rid="F3">3D</xref>) in 61% of transgenic embryos (n = 38), and in 0% of non-transgenic siblings (n = 82). Decrease of <italic>foxP2 </italic>telencephalic expression is presumably due to a dominant effect of the transgene, since the decrease was not seen using the morpholino or Df(<italic>LG01</italic>)<sup>x8</sup>.</p><p>The loss of <italic>foxP2 </italic>expression in the tectum and hindbrain is not secondary to an absence of cells, as expression of the tectal marker <italic>mbx </italic>[<xref ref-type="bibr" rid="B31">31</xref>] is indistinguishable between wild type and <italic>lef1 </italic>morphants (Figure <xref ref-type="fig" rid="F3">3E, F</xref>). Other markers for the tectum (<italic>emx2</italic>), and hindbrain (<italic>isl1, zash1a</italic>) of <italic>lef1 </italic>morphants also appear as wild type patterns and levels [<xref ref-type="bibr" rid="B27">27</xref>]; J.E.L. and R.I.D., unpublished data). Furthermore, the loss of <italic>foxP2 </italic>expression persists at 48 hpf (Additional File <xref ref-type="supplementary-material" rid="S1">1</xref>). These results show that loss of <italic>lef1 </italic>specifically causes loss of <italic>foxP2 </italic>expression in the tectum, MHB, and hindbrain.</p></sec><sec><title>Identification of <italic>foxP2 </italic>genomic enhancers and Lef1 binding sites</title><p>6 potential conserved binding sites for <italic>lef</italic>/<italic>tcf </italic>family transcription factors were identified in the <italic>FOXP2 </italic>genomic locus of mouse and pufferfish using <italic>in silico </italic>analysis [<xref ref-type="bibr" rid="B25">25</xref>]. This algorithm (enhancer element locator) aligns transcription factor sequence sites from orthologous genomic regions between two species, with scoring of the sites determined by conservation, affinity, and clustering of sites. Based on conserved synteny between zebrafish, mouse, and pufferfish, we initially were able to identify 5 of these sites in the zebrafish <italic>foxP2 </italic>genomic locus using Sanger Centre genome assembly Zv6 (see Methods; Figure <xref ref-type="fig" rid="F4">4A</xref>).</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Genomic structure and identification of enhancers of <italic>foxP2</italic></bold>. (A) <italic>foxP2 </italic>genomic region (not to scale). Coding exons are shown as solid black boxes. Predicted <italic>lef1 </italic>binding sites are shown as ovals. DNA fragments tested for enhancer activity are shown. (B) Schematic of cloning strategy for DNA fragments. PCR primers for the genomic region of interest (red box) are designed with <italic>attB4 </italic>and <italic>attB1 </italic>sites (blue boxes), and the region is amplified and cloned using a BP reaction into an entry clone. A LR reaction is performed to recombine the entry clone (containing the genomic DNA fragment) into a Tol2 destination vector, placing the genomic fragment upstream of a basal promoter and EGFP (green box). (C) Summary table of expression patterns of the different enhancers at 72 hpf in the CNS.</p></caption><graphic xlink:href="1471-213X-8-103-4"/></fig><p>Because the <italic>foxP2 </italic>genomic assembly is incomplete in the region upstream of the 2<sup>nd </sup>coding exon (J.L.B., unpublished data), we sought to identify the sixth predicted <italic>lef1 </italic>binding site. In human <italic>FOXP2 </italic>this site is 8.8 kb upstream of the first coding exon. We obtained the sequence for this region in zebrafish from the unassembled BAC DKEY-116L11. Using the enhancer element locator algorithm [<xref ref-type="bibr" rid="B25">25</xref>], we compared the 9 kb regions immediately upstream of the first coding exon of <italic>foxP2 </italic>from the human and zebrafish genomes. We found conservation of this same element (zebrafish: ttgtgggctGCTTTCATCtgtgggttaa; human: atgatcagtGCTTTCATCtttattttaa) located 8.5 kb upstream of the first coding exon in zebrafish (contained within foxP2-enhancerA).</p><p>To identify <italic>foxP2 </italic>enhancers, and to determine whether any of the potential <italic>lef1 </italic>sites might function <italic>in vivo </italic>in the context of enhancer elements, we cloned genomic fragments containing the sites into a Tol2 transposon-based vector (Figure <xref ref-type="fig" rid="F4">4B</xref>) [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>]. To visualize expression controlled by the potential enhancers, each DNA fragment was cloned immediately upstream of GFP under control of a minimal promoter [<xref ref-type="bibr" rid="B32">32</xref>]. In total we cloned nine genomic DNA fragments (Figure <xref ref-type="fig" rid="F4">4A</xref>), from five different regions, containing the six predicted <italic>lef1 </italic>sites (two sites are contained in foxP2-fragmentC). To test for expression, we injected one cell stage embryos and assayed GFP expression from 12 hpf through 96 hpf (Figure <xref ref-type="fig" rid="F4">4C</xref>). Subsequent analysis used stable transgenic lines, which mostly reproduced the same patterns of expression. Three of the regions, foxP2-enhancerA, B, and D, drove GFP expression in patterns partially recapitulating <italic>foxP2 </italic>expression (Figure <xref ref-type="fig" rid="F5">5</xref>). Potential enhancers foxP2-fragmentC and foxP2-fragmentE had no expression.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Confocal live whole-mount images of <italic>foxP2 </italic>enhancers</bold>. Pictures show GFP expression at 72 hpf (except foxP2-enhancerD, taken at 48 hpf). The eye has been removed in panels E and G to facilitate visualization. Scale bar = 100 &#x003bc;m. (A, C, E, G, I): lateral views, anterior left, dorsal up. (B, D, F, H, J): dorsal views, anterior up. (Abbreviations: di, diencephalon; hb, hindbrain; tec, tectum; tel, telencephalon; arrows, GFP-expressing cells in the eye. (A, B) Tg(<italic>foxP2-enhancerA:EGFP)</italic><sup><italic>zc42</italic></sup>; (C, D) Tg(<italic>foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44</italic></sup>; (E, F) Tg(<italic>foxP2-enhancerA.2:EGFP</italic>)<sup><italic>zc46</italic></sup>; (G, H) Tg(<italic>foxP-enhancerB:EGFP)</italic><sup><italic>zc41</italic></sup>; (I, J) Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47</italic></sup>.</p></caption><graphic xlink:href="1471-213X-8-103-5"/></fig><p>foxP2-enhancerA drove expression in the eye, diencephalon, tectum, hindbrain, and telencephalon (Figure <xref ref-type="fig" rid="F5">5A, B</xref>). GFP expression was first noted in the telencephalon at 24 hpf, then at 48 hpf in the eye, tectum and hindbrain, becoming maximal at 72 hpf. By 80 hpf expression in the CNS diminished significantly, while jaw expression became visible. Subcloning of foxP2-enhancerA to yield enhancerA.1 and A.2 revealed very similar patterns to foxP2-enhancerA (Figure <xref ref-type="fig" rid="F5">5C&#x02013;F</xref>). However, enhancerA.2 had significantly fewer labeled cells, suggesting that the more proximal region of enhancerA and enhancerA.1 contains necessary elements. foxP2-enhancerB expression in the telencephalon began at 24 hpf, with eye and hindbrain expression apparent by 72 hpf (Figure <xref ref-type="fig" rid="F5">5G, H</xref>). foxP2-enhancerD expression in the eye, dorsal diencephalon, and tectum began at 36 hpf, was maximal at 48 hpf, and decreased by 72 hpf (Figure <xref ref-type="fig" rid="F5">5I, J</xref>).</p><p>The enhancers we have identified partially mirror endogenous <italic>foxP2 </italic>expression [<xref ref-type="bibr" rid="B7">7</xref>]. While the enhancer fragments were chosen based on <italic>in silico </italic>prediction of potential <italic>lef1 </italic>binding sites [<xref ref-type="bibr" rid="B25">25</xref>], our analysis shows the importance of <italic>in vivo </italic>validation, since only 3 of the 6 predicted binding sites appear to lie in functional enhancer elements for the stages analyzed.</p></sec><sec><title><italic>lef1 </italic>knockdown leads to loss of expression from foxP2-enhancers A.1, B, and D</title><p>Based on our observations that foxP2-enhancers A.1, B, and D show expression in a pattern mirroring <italic>lef1 </italic>expression in the tectum and hindbrain, and contained putative binding sites for Lef1, we tested whether knockdown of <italic>lef1 </italic>led to loss of GFP expression. We injected <italic>lef1 </italic>morpholino into stable transgenic <italic>foxP2 </italic>enhancer lines (Tg<italic>(foxP2-enhancerA.1:EGFP</italic>)<sup>zc44</sup>, Tg<italic>(foxP2-enhancerB:EGFP)</italic><sup><italic>zc</italic>41</sup>, Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc</italic>47</sup>), and looked for GFP expression in the tectum and hindbrain at 36 hpf. To detect enhancer-driven transcription with maximum sensitivity, we used an <italic>in situ </italic>probe for <italic>gfp</italic>. Morphants showed a loss of GFP expression in the tectum and hindbrain, but maintenance of telencephalic expression, in 89% of enhancerA.1 embryos (n = 71), 100% of enhancerB embryos (n = 22), and 100% of enhancerD embryos (n = 27) (Figure <xref ref-type="fig" rid="F6">6A&#x02013;F</xref>). In contrast, in uninjected embryos only 2%, 0%, and 0% (n = 58, 15, and 16), respectively, showed loss of tectum and hindbrain expression. Further, the <italic>lef1</italic>-mediated loss of expression from the enhancers was visible at 52 hpf by visualization of GFP (Additional File <xref ref-type="supplementary-material" rid="S2">2</xref>).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold><italic>lef1 </italic>is necessary for expression from foxP2-enhancerA.1, foxP2-enhancerB, and foxP2-enhancerD</bold>. Whole-mount <italic>gfp in situ</italic>s at 36 hpf; anterior to left, dorsal up, eyes removed. Scale bar = 50 &#x003bc;m. Conditions (wild type, wt; or <italic>lef1 </italic>morphant, <italic>lef1 </italic>MO) are shown above the panels, enhancer names to left. (Abbreviations: dd, dorsal diencephalon; hb, hindbrain; tec, tectum; tel, telencephalon.) (A) Tg<italic>(foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44 </italic></sup>expresses in telencephalon, tectum, and hindbrain. (B) Tg<italic>(foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino lacks GFP expression in tectum and hindbrain (<italic>arrows</italic>), although telencephalic expression persists. (C) Tg(<italic>foxP2-enhancerB:EGFP</italic>)<sup><italic>zc41 </italic></sup>expresses in telencephalon and hindbrain. (D) Tg(<italic>foxP2-enhancerB:EGFP</italic>)<sup><italic>zc41 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino lacks GFP expression in the hindbrain (<italic>arrow</italic>), but telencephalic expression is present. (E) Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47 </italic></sup>expresses in dorsal diencephalon and tectum. (F) Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino lacks GFP expression in the tectum (arrow), but dorsal diencephalic expression persists. (G) Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>embryo shows GFP expression in all post-mitotic neurons. (H) Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino still has GFP expression in the tectum and hindbrain.</p></caption><graphic xlink:href="1471-213X-8-103-6"/></fig><p>To demonstrate that loss of GFP expression in the <italic>lef1 </italic>morphants was not simply due to absence of the GFP-expressing cells, we injected <italic>lef1 </italic>morpholino into transgenic fish lines Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>(also known as <italic>HuC:GFP</italic>) and Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1</italic></sup>. Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>expresses GFP in all post-mitotic neurons [<xref ref-type="bibr" rid="B35">35</xref>], while Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1 </italic></sup>expresses GFP in a pattern mirroring <italic>pax2a </italic>expression, including in the MHB, cerebellum, and hindbrain [<xref ref-type="bibr" rid="B36">36</xref>]. In both lines we found that <italic>lef1 </italic>morphants still expressed GFP in the tectum, MHB, and hindbrain (Figure <xref ref-type="fig" rid="F6">6G, H</xref>, and Additional File <xref ref-type="supplementary-material" rid="S2">2</xref>). In addition, using Tg(<italic>isl3:GFP</italic>)<sup>zc7 </sup>to label retinal axons (A. Pittman and C.B.C., unpublished), we observed that the pattern of retinotectal projections appeared normal in 48 hpf morphants (data not shown). Although overall numbers of GFP-expressing cells appeared reduced in <italic>lef1 </italic>morphants of Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>and Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1</italic></sup>, in the <italic>foxP2 </italic>enhancer lines there was a complete lack of GFP-expressing cells in the tectum and hindbrain. These results show that loss of tectal and hindbrain expression observed with the <italic>lef1 </italic>morpholino in foxP2-enhancerA.1, foxP2-enhancerB, and foxP2-enhancerD is not simply due to a loss of neurons, but instead indicates a requirement for <italic>lef1 </italic>in these enhancers' function.</p></sec><sec><title>Chromatin immunoprecipitation identifies critical Lef1 binding sites in foxP2-enhancerA.1 and foxP2-enhancerB</title><p>To test whether Lef1 can bind to foxP2-enhancerA.1 and foxP2-enhancerB to regulate <italic>foxP2 </italic>expression, we performed chromatin immunoprecipitation (ChIP) using a polyclonal antibody against zebrafish Lef1 [<xref ref-type="bibr" rid="B27">27</xref>]. We designed PCR amplicons to test different regions of foxP2-enhancerA.1 and foxP2-enhancerB (Figure <xref ref-type="fig" rid="F7">7A</xref>), using chromatin extracted from 30 hpf embryos. For foxP2-enhancerA.1, we found that PCR amplicon FP2700 (centered around base pair 2700 in the enhancerA.1 DNA fragment) showed significant enrichment compared to controls (no antibody, and extracts from homozygous Df(<italic>LG01</italic>)<sup>x8 </sup>embryos) (Figure <xref ref-type="fig" rid="F7">7B</xref>). Interestingly, amplicon FP300, encompassing the predicted Lef1 binding site in foxP2-enhancerA.1 (Figure <xref ref-type="fig" rid="F7">7A</xref>), showed minimal enrichment (Figure <xref ref-type="fig" rid="F7">7B</xref>). Further, a deletion construct of foxP2-enhancerA:GFP, removing the region containing FP300, did not cause loss of GFP expression (data not shown). This suggests that maximal Lef1 binding for foxP2-enhancerA.1 is centered around FP2700. For foxP2-enhancerB, we found that FPb2600 had significant enrichment compared to controls (Figure <xref ref-type="fig" rid="F7">7C</xref>). This PCR amplicon contains a predicted Lef1 binding site [<xref ref-type="bibr" rid="B25">25</xref>] (Figure <xref ref-type="fig" rid="F7">7A</xref>). We therefore conclude that Lef1 directly interacts with regulatory regions of <italic>foxP2 </italic>in 30 hpf zebrafish embryos.</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>ChIP analysis of foxP2-enhancerA.1 and foxP2-enhancerB genomic regions at 30 hpf</bold>. (A) Diagram of foxP2-enhancerA.1 and foxP2-enhancerB regions. PCR amplicon locations and names are indicated above the genomic region; predicted Lef1 binding sites are shown as ovals. (B) Agarose gel analysis of ChIP PCR for foxP2-enhancerA.1, showing the PCR products for FP2700, FP300, and B3end. In wild type (wt) embryos, ChIP shows significant enrichment of the FP2700 product and slight enrichment of the FP300 product, compared to both the no antibody (Ab) control, and the ChIP of homozygous Df(<italic>LG01</italic>)<sup>x8 </sup>embryos (Mock: water control for the PCR reaction.) In contrast, the B3end product showed no enrichment relative to the Df(<italic>LG01</italic>)<sup>x8 </sup>embryos. (C) Agarose gel analysis of ChIP PCR for foxP2-enhancerB, showing the FPb2600 PCR product. In wt embryos, ChIP shows significant enrichment of the FPb2600 product, compared to both the no antibody and homozygous Df(<italic>LG01</italic>)<sup>x8 </sup>controls.</p></caption><graphic xlink:href="1471-213X-8-103-7"/></fig></sec></sec><sec><title>Discussion</title><p>Our data show that <italic>lef1 </italic>and <italic>foxP2 </italic>expression overlap in the developing CNS, and that <italic>lef1 </italic>is necessary for <italic>foxP2 </italic>expression in the tectum, MHB, and hindbrain. We identified Lef1binding sites in the <italic>foxP2 </italic>regulatory regions, based on the identification of <italic>foxP2 </italic>enhancers that depend on <italic>lef1 </italic>for expression, and ChIP analysis showing binding of Lef1 to these enhancers.</p><p><italic>lef1 </italic>regulation appears to be a combination of both direct and indirect effects on <italic>foxP2 </italic>(Figure <xref ref-type="fig" rid="F8">8</xref>). In the tectum and MHB, <italic>lef1 </italic>expression precedes <italic>foxP2 </italic>expression. Loss of <italic>lef1 </italic>leads to loss of both endogenous <italic>foxP2 </italic>expression, and expression from <italic>foxP2 </italic>enhancers. In the hindbrain loss of <italic>lef1 </italic>also leads to a loss of <italic>foxP2 </italic>expression. Since <italic>lef1 </italic>expression is not detectable in the hindbrain, we hypothesize that loss of <italic>foxP2 </italic>expression occurs both via an inductive effect of <italic>lef1 </italic>expression in the MHB, and through a second gene regulated by <italic>lef1 </italic>(Figure <xref ref-type="fig" rid="F8">8</xref>). This model would explain why we observe <italic>foxP2 </italic>expression (both by <italic>in situ </italic>and by expression from its enhancers) in the hindbrain (where <italic>lef1 </italic>is not expressed), as well as why <italic>foxP2 </italic>expression persists after <italic>lef1 </italic>expression in the MHB stops. In addition, our data demonstrate that <italic>foxP2 </italic>expression in the telencephalon, including the subpallium/basal ganglia, is regulated independently of <italic>lef1</italic>.</p><fig position="float" id="F8"><label>Figure 8</label><caption><p><bold>Model of <italic>foxP2 </italic>regulation in the CNS</bold>. In the telencephalon, an unknown factor X activates <italic>foxP2 </italic>expression. In the tectum (and MHB) Lef1 directly binds to enhancer elements of <italic>foxP2</italic>, leading to <italic>foxP2 </italic>expression. In the hindbrain expression of <italic>foxP2 </italic>is Lef1-dependent, but indirectly, since Lef1 is not expressed in the hindbrain.</p></caption><graphic xlink:href="1471-213X-8-103-8"/></fig><p>Since <italic>foxP2 </italic>expression in the telencephalon is not <italic>lef1</italic>-dependent, other factors must regulate <italic>foxP2</italic>. Conversely, in regions where <italic>lef1 </italic>is expressed but <italic>foxP2 </italic>is not, for example the dorsal diencephalon, lack of <italic>foxP2 </italic>expression could either reflect an absence of some necessary co-factors, or the presence of an inhibitor of expression, or both mechanisms. We have tried to globally activate <italic>foxP2 </italic>by heat-shock induction of a constitutively active form of <italic>tcf3 </italic>(RID, unpublished data), but did not observe any ectopic <italic>foxP2 </italic>expression (data not shown), implying stringent, multifactorial control of <italic>foxP2 </italic>expression.</p><p>Previous computer algorithm-based methods identified several other potential Lef1 binding sites in the <italic>foxP2 </italic>genomic region [<xref ref-type="bibr" rid="B25">25</xref>], but our <italic>in vivo </italic>analysis failed to support a role for them. Another recently described <italic>in silico </italic>method to identify transcription factor target genes would also fail to identify the <italic>lef1 </italic>enhancers for <italic>foxP2</italic>, as this method only included the 5 kb regions immediately upstream of transcriptional start sites [<xref ref-type="bibr" rid="B37">37</xref>]. Our work shows the importance of actual <italic>in vivo </italic>testing for analysis of enhancer gene regulation.</p><p>Since we analyzed expression up to 96 hours after fertilization, enhancers responsible for controlling expression at later times might have been missed. Given that all of the CNS domains of expression for <italic>foxP2 </italic>are present by 72 hpf [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B11">11</xref>], we feel that this is unlikely. However, we can not exclude the possibility that untested genomic regions might regulate expression, or that several independent regions might function in concert.</p><p>This study identified three regions functioning as enhancers for <italic>foxP2</italic>, specifically driving expression in the telencephalon, eye, diencephalon, tectum, and hindbrain. Their expression reveals that <italic>foxP2 </italic>is expressed in multiple brain regions, under strict temporal and spatial control, regulated through both <italic>lef1</italic>-dependent and -independent mechanisms. These transgenic lines label multiple distinct axon tracts (data not shown), and will allow analysis of subsets of <italic>foxP2 </italic>neurons and axons, in both wild type and mutant backgrounds, as well as misexpression and rescue experiments.</p><p>The role of <italic>foxP2 </italic>in CNS development has remained elusive, despite multiple genetic studies in humans demonstrating its necessity for normal language development [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. In affected members of the human KE family, who carry a heterozygous point mutation which disrupts the function of one copy of <italic>FOXP2</italic>, voxel-based morphometric MRI analyses suggest disturbances in Broca's area, the basal ganglia, and the cerebellum [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>]. Studies of <italic>FoxP2 </italic>knockout or point mutation mice have consistently shown cerebellar involvement. Homozygotes have been reported to have disordered Purkinje cell layering [<xref ref-type="bibr" rid="B17">17</xref>-<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B40">40</xref>] and smaller cerebellar size [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B20">20</xref>], while heterozygotes are noted to display impaired motor learning and altered Purkinje cell synaptic plasticity [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>]. Our identification of <italic>lef1 </italic>as a regulator of <italic>foxP2 </italic>expression in the MHB and hindbrain is a first step towards understanding the <italic>foxP2 </italic>genetic network involved in cerebellar development. The role of the cerebellum in language function is at least partially understood [<xref ref-type="bibr" rid="B41">41</xref>], but it is uncertain whether the oromotor apraxia of the KE family is due to defects of cerebellar or striatal pathways (or both) [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. Importantly, other domains of <italic>foxP2 </italic>expression, for example in the telencephalon (including the subpallium), appear to be regulated independently of <italic>lef1</italic>.</p></sec><sec><title>Conclusion</title><p>Wnt signaling has multiple roles in neuronal specification and the development of connectivity in the CNS [<xref ref-type="bibr" rid="B26">26</xref>], as does <italic>lef1</italic>, which is activated by the canonical Wnt signaling cascade. <italic>lef1 </italic>is necessary for development of dentate gyrus neurons [<xref ref-type="bibr" rid="B44">44</xref>], for neurogenesis and specification of neuronal subsets in the hypothalamus [<xref ref-type="bibr" rid="B27">27</xref>], and for expression of the transcription factors <italic>zic2a </italic>and <italic>zic5 </italic>in the tectum [<xref ref-type="bibr" rid="B45">45</xref>]. Here we show that <italic>lef1 </italic>regulates <italic>foxP2 </italic>expression in the tectum, MHB, and hindbrain. Interestingly, ChIP studies suggest that <italic>FOXP2 </italic>may in turn regulate components of the Wnt signaling pathway [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. The identification of components of the <italic>foxP2 </italic>signaling cascade, including upstream, interacting, and downstream members, will be important for understanding <italic>foxP2 </italic>function, and for elucidating the genes and neural circuits involved in language development.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Fish stocks and embryo raising</title><p>Adult fish were bred according to standard methods. Embryos were raised at 28.5&#x000b0;C in E3 embryo medium with 0.003% phenylthiourea to inhibit pigment formation and staged by time and morphology [<xref ref-type="bibr" rid="B46">46</xref>]. For <italic>in situ </italic>staining, embryos were fixed in 4% paraformaldehyde (PFA) (in PBS) for 3 h at room temperature (RT) or overnight (O/N) at 4&#x000b0;C, washed briefly in PBS, dehydrated, and stored in 100% MeOH at -20&#x000b0;C until use.</p><p>Transgenic fish lines and alleles used were as follows: Df(<italic>LG01</italic>)<sup>x8 </sup>[<xref ref-type="bibr" rid="B29">29</xref>]; Tg<italic>(hsp70l:&#x00394;tcf-GFP)</italic><sup><italic>w26 </italic></sup>[<xref ref-type="bibr" rid="B30">30</xref>]; Tg<italic>(foxP2-enhancerA:EGFP)</italic><sup><italic>zc42</italic></sup>; Tg<italic>(foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44</italic></sup>; Tg(<italic>foxP2-enhancerA.2:EGFP</italic>)<sup><italic>zc46</italic></sup>; Tg<italic>(foxP2-enhancerB:EGFP)</italic><sup><italic>zc41</italic></sup>; Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47</italic></sup>; Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1 </italic></sup>[<xref ref-type="bibr" rid="B36">36</xref>]; Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>[<xref ref-type="bibr" rid="B35">35</xref>]. Df(<italic>LG01</italic>)<sup>x8 </sup>homozygotes were identified by their smaller forebrain and flattened hindbrain phenotype (J.E.L. and R.I.D., unpublished). Tg<italic>(hsp70l:&#x00394;tcf-GFP)</italic><sup><italic>w26 </italic></sup>embryos were identified by GFP expression after heat shock.</p><p>Heat shock was performed by incubation of 32 hpf embryos for 1 hour at 37&#x000b0;C, then collecting 3 hours after the end of the heat shock.</p></sec><sec><title><italic>In situ </italic>hybridization</title><p>Whole-mount <italic>in situ </italic>labeling for <italic>foxP2</italic>, <italic>gfp</italic>, and <italic>lef1 </italic>was performed as previously described [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B47">47</xref>]; the <italic>mbx </italic>RNA probe derived from full-length <italic>mbx </italic>cDNA cloned into pBluescript [<xref ref-type="bibr" rid="B31">31</xref>]. Double <italic>in situs </italic>were performed using a DNP-labeled probe for <italic>foxP2 </italic>and digoxigenin-labeled probe for <italic>lef1</italic>. Following standard hybridization and washes, DNP probe was detected using an anti-DNP HRP conjugate diluted 1:200 in TNTB block at 4&#x000b0;C overnight (PerkinElmer; [<xref ref-type="bibr" rid="B48">48</xref>]), followed by detection using Alexa Fluor 488 Tyramide diluted 1:250 (Molecular Probes) with 0.0015% hydrogen peroxide for 1 hour. Embryos were washed in TNT, blocked in TNTB, incubated with anti-digoxigenin alkaline phosphatase diluted 1:5000 in TNTB at 4&#x000b0;C overnight, and then detected with a standard BM Purple color reaction.</p></sec><sec><title>Genomic PCR and Enhancer Cloning</title><p>PCR primers to clone <italic>foxP2 </italic>genomic fragments were as follows (forward and reverse primers, sequences 5' to 3'; size in kb listed immediately following the enhancer name): foxP2-enhancerA (9.7 kb): FP2.12L GTCGTAATTGCTCGGTGAC, FP2.3R GTGTGAATGCCAGCGATAGA; foxP2-enhancerA.1 (6.8 kb): FP2.12L, FP2.16R CGTCTCGACTGAGCAGAGTT; foxP2-enhancerA.2 (5.1 kb): FP2.12L, FP2.46R ACAACTGGCGTGTAAGGTGT; foxP2-fragment A.3 (4.7 kb): FP2.41L GACACCTTACACGCCAGTTG, FP2.3R; foxP2-fragment A.4 (2.3 kb): FP2.41L, FP2.40R CAGGGTGTGTTATAAACATGCAT; foxP2-enhancerB (4.6 kb): FP2.39L GACACTCTGGAGGAACTATG, FP2.38R GGAAACGGTGCAGTATGTGT; foxP2-fragment C (1.6 kb): F.FP1 GGCGGGTACCTGGTCATATT, F.RP2 TTTCCACCCAACCATAAATCA; foxP2-enhancerD (1.2 kb): H.FP1 CCAGCTATCCGAGAGGTTCA, H.RP2 CCGCCTGTTCAAATCAGAAT; foxP2-fragment E (0.69 kb): G.FP1 TGACCTCTGTGTAGCCTTGC, G.RP2 CATTGCTAGGGGAACGTGAT.</p><p>PCR was performed using standard conditions (TaKaRa LA PCR amplification kit 2.1, Millipore) from total genomic DNA, and PCR fragments gel purified prior to cloning (Qiagen gel purification kit). BP and LR reactions (Gateway cloning system, Invitrogen) were performed to clone the DNA fragments upstream of an adenovirus E1b minimal promoter and carp &#x003b2;-actin transcriptional start fused to EGFP (pENTRbasEgfp) in a Tol2 plasmid backbone (pTolR4-R2) [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. BP reactions were performed by adding attB4 sequence to the 5' primer (5'-GGGGACAACTTTGTATAGAAAAGTTG-gene specific primer-3'), and attB1 sequence to the 3' primer (5'-GGGGACTGCTTTTTTGTACAAACTTG-gene specific primer-3'). The identity of the genomic fragments was confirmed by restriction enzyme digests and partial sequencing.</p><p>Injection of DNA constructs and raising of stable transgenic lines was performed essentially as described [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. 20 pg of each enhancer:EGFP-Tol2 construct was co-injected with 20 pg of Tol2 transposase RNA in a total volume of 1 nL at the 1-cell stage. Embryos were screened for GFP expression from 12 hpf through 96 hpf. Patterns of enhancer expression were confirmed by multiple independent transient injections of the plasmid (&#x0003e; 5 injections for all constructs, &#x0003e; 100 embryos per injection), as well as isolation of 2 or more independent stable transgenic lines (in cases where stable transgenics were isolated).</p></sec><sec><title>Morpholino oligonucleotide sequences</title><p>The <italic>lef1 </italic>and <italic>tcf3b </italic>splice-blocking morpholinos (MO) were synthesized by Gene Tools (Philomath, OR); efficacy and use were as previously described [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>]. For <italic>lef1</italic>, 2 ng of morpholino E7I7 was injected; for <italic>tcf3b</italic>, 5 ng was injected.</p></sec><sec><title>Microscopy and image analysis</title><p>Whole-mount images were taken using brightfield microscopy with embryos mounted in 80% glycerol. Confocal microscope images of live embryos were taken after mounting embryos anesthetized using tricaine (0.004%) in 1.5% low melt agarose dissolved in 0.33&#x000d7; PBS/7.3% glycerol. Image acquisition and analysis were performed as described previously [<xref ref-type="bibr" rid="B52">52</xref>]. Confocal images of double <italic>in situ</italic>s were taken on an Olympus FV1000 after mounting embryos in 80% glycerol. BM Purple fluorescence was imaged with 633 nm excitation, collecting emission from 700&#x02013;800 nm [<xref ref-type="bibr" rid="B53">53</xref>].</p></sec><sec><title>Sequence Analysis</title><p>We used coordinate conversion ("convert" function) in the UCSC genome web server <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/goldenPath/help/hgTracksHelp.html#Convert"/>[<xref ref-type="bibr" rid="B54">54</xref>] to identify conserved <italic>lef1 </italic>binding sites in the <italic>foxP2 </italic>region of zebrafish, based on predicted Tcf4 binding sites positions in the human genome (since Tcf4 and Lef1 bind to a shared motif) [<xref ref-type="bibr" rid="B25">25</xref>]. The genomic upstream sequence of <italic>foxP2 </italic>was obtained by performing a BLAST search against unfinished sequences in the Sanger Centre <italic>Danio rerio </italic>sequencing project (sequence for foxP2-enhancerA is contained in BAC DKEY-116L11; GenBank accession <ext-link ext-link-type="gen" xlink:href="CU468733">CU468733</ext-link>). To identify the sixth potential Lef1 binding site in the foxP2-enhancerA region predicted by Hallikas et al. [<xref ref-type="bibr" rid="B25">25</xref>], we used the enhancer element locator algorithm (available at <ext-link ext-link-type="uri" xlink:href="http://www.cs.helsinki.fi/u/kpalin/EEL/"/>, and compared the 9 kb regions upstream of the first coding exon of human and zebrafish <italic>FOXP2 </italic>using the Tcf4 consensus binding motif.</p></sec><sec><title>Chromatin immunoprecipitation (ChIP)</title><p>ChIP was performed as previously described [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B55">55</xref>] with the following modifications. 80&#x02013;120 embryos of each genotype (wild type or homozygous Df(<italic>LG01</italic>)<sup>x8</sup>) were collected between 28 hpf and 30 hpf, dechorionated, and fixed in 2.2% formaldehyde for 15 minutes at room temperature. Embryos were rinsed in 0.125 M glycine, followed by PBS, and then lysed. The Df(<italic>LG01</italic>)<sup>x8 </sup>lysate was checked by genomic PCR for the <italic>lef1 </italic>gene to confirm that no PCR product was obtained. PCR products were visualized on ethidium bromide-stained agarose gels. Primers used for ChIP analysis of the foxP2-enhancerA.1 genomic region were the following (forward and reverse primers, sequences 5' to 3'): FP300, CGACTCTCCGCGAAACAC, CATTGCCATTATCACCAGCA; FP900, CCTATCAAAGGCAGGCAGA, TTATCGCACTAAACAAGCTATTACAC; FP1800, CACAGAGTGAAGTCATGGAGAAA, AGCGCACGCACAACTAATC; FP2700, AGAGAAACGGATAAACAGTGAGAAG, CCCTCTCGAACCCTCAAAA; B3end, TGATTAACGCCGTCTTTTCC, AGCGCACGCACAATAAAATA. Primers used for ChIP analysis of the foxP2-enhancerB genomic region were (forward and reverse primers, sequences 5' to 3'): FPb200, AGCTGGAAGGAAGTGTCTGG, TTTTGGCATGTGCAAAGAAG; FPb1500, GCGTATGTATGCTTGTCAGGTT, TGCGTGGTGTTTTACTTGGA; FPb2600, CAGATCGACGGATGATACACA, TTCCGCCAATTATCATGTCA; FPb3800, GACCCCTTCGCAATGTCTAAT, TTCGAGAAATGCTTGCACAC.</p></sec></sec><sec><title>Abbreviations</title><p>ChIP: chromatin immunoprecipitation; CNS: central nervous system; MHB: mid-hindbrain boundary;</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>JLB and EF jointly carried out cloning and <italic>in situ</italic>s. XW performed ChIP. JLB and JEL performed expression analysis. JLB, CBC, and RID conceived the study, and participated in its design and coordination. JLB was largely responsible for writing the manuscript. All authors read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Loss of <italic>lef1 </italic>leads to absent <italic>foxP2 </italic>expression in the tectum, mid-hindbrain boundary, and hindbrain</bold>. Whole-mount <italic>in situ</italic>s at 48 hpf; anterior to left, dorsal up, eyes removed. Scale bar = 50 &#x003bc;m. (Conditions: hs:&#x00394;tcf- Tg<italic>(hsp70l:&#x00394;tcf:GFP</italic>)<sup>w26</sup>, <italic>lef1 </italic>mo- <italic>lef1 </italic>morphants, wt- wild type, x8- homozygous Df(<italic>LG01</italic>)<sup>x8</sup>. Abbreviations: hb: hindbrain; mhb: mid-hindbrain boundary; tec: tectum; tel: telencephalon.) (A, B) <italic>lef1 </italic>morphant (B) lacks expression in tectum and has diminished expression in the hindbrain (<italic>arrows</italic>), compared to wild-type (A). (C) In Df(<italic>LG01</italic>)<sup>x8 </sup>homozygote, expression is absent in the tectum and hindbrain (<italic>arrows</italic>). (D) In Tg<italic>(hsp70l:&#x00394;tcf:GFP</italic>)<sup>w26 </sup>embryo, collected four hours after heat shocking, expression is absent from the tectum and hindbrain (<italic>arrows</italic>). MHB expression is reduced but not absent, perhaps because <italic>lef1 </italic>induction of <italic>foxP2 </italic>expression is already sufficiently established by the time of heat-shock.</p></caption><media xlink:href="1471-213X-8-103-S1.tiff" mimetype="image" mime-subtype="tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold><italic>lef1 </italic>is necessary for expression from foxP2-enhancerA.1, foxP2-enhancerB, and foxP2-enhancerD</bold>. Whole-mount confocal images at 52 hpf (except foxP2-enhancerD), lateral view, anterior left, dorsal up. Conditions (wild type- wt, or <italic>lef1 </italic>morphant- <italic>lef1 </italic>MO) are shown above the panels, while the enhancer name is to the left of the panels. (Abbreviations: hb: hindbrain; tec: tectum; tel: telencephalon.) (A) Tg<italic>(foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44 </italic></sup>expresses in telencephalon, tectum, and hindbrain. (B) Tg<italic>(foxP2-enhancerA.1:EGFP)</italic><sup><italic>zc44 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino: GFP expression is absent in the tectum and hindbrain (<italic>arrows</italic>), although telencephalic expression persists. (C) Tg(<italic>foxP2-enhancerB:EGFP</italic>)<sup><italic>zc41 </italic></sup>expresses in telencephalon, tectum, and hindbrain. (D) Tg(<italic>foxP2-enhancerB:EGFP</italic>)<sup><italic>zc41 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino: GFP expression is absent in the hindbrain (<italic>arrow</italic>), but still present in the telencephalon. (E) Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47 </italic></sup>expresses in tectum. (F) Tg<italic>(foxP2-enhancerD:EGFP)</italic><sup><italic>zc47 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino: GFP expression is absent in the tectum (arrow). (G) Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>embryo shows GFP expression in all post-mitotic neurons. (H) Tg(<italic>elavl3:EGFP</italic>)<sup><italic>zf8 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino: GFP expression is still present in the tectum and hindbrain. (I) Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1 </italic></sup>embryo shows expression in the MHB and hindbrain. (J) Tg<italic>(pax2a:GFP</italic>)<sup><italic>e1 </italic></sup>embryo injected with <italic>lef1 </italic>morpholino has persistent expression in the MHB and hindbrain.</p></caption><media xlink:href="1471-213X-8-103-S2.tiff" mimetype="image" mime-subtype="tiff"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>We thank members of the Chien and Dorsky labs for their assistance. This work was supported by a PCMC Foundation grant and CHRC grant to JLB, NIH K12 HD001410 and K08 DA024753 to JLB, and NIH R01 NS053897 to RID.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CS</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Hurst</surname><given-names>JA</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name><name><surname>Monaco</surname><given-names>AP</given-names></name></person-group><article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title><source>Nature</source><year>2001</year><volume>413</volume><fpage>519</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">11586359</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Feuk</surname><given-names>L</given-names></name><name><surname>Kalervo</surname><given-names>A</given-names></name><name><surname>Lipsanen-Nyman</surname><given-names>M</given-names></name><name><surname>Skaug</surname><given-names>J</given-names></name><name><surname>Nakabayashi</surname><given-names>K</given-names></name><name><surname>Finucane</surname><given-names>B</given-names></name><name><surname>Hartung</surname><given-names>D</given-names></name><name><surname>Innes</surname><given-names>M</given-names></name><name><surname>Kerem</surname><given-names>B</given-names></name><name><surname>Nowaczyk</surname><given-names>MJ</given-names></name><etal></etal></person-group><article-title>Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia</article-title><source>Am J Hum Genet</source><year>2006</year><volume>79</volume><fpage>965</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17033973</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>PA</given-names></name><name><surname>Cooper</surname><given-names>ML</given-names></name><name><surname>Peiffer</surname><given-names>DA</given-names></name><name><surname>Gunderson</surname><given-names>KL</given-names></name><name><surname>Patel</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>S</given-names></name><name><surname>Cheung</surname><given-names>SW</given-names></name><name><surname>Bacino</surname><given-names>CA</given-names></name></person-group><article-title>Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review</article-title><source>Am J Med Genet A</source><year>2007</year><volume>143</volume><fpage>791</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17330859</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacDermot</surname><given-names>KD</given-names></name><name><surname>Bonora</surname><given-names>E</given-names></name><name><surname>Sykes</surname><given-names>N</given-names></name><name><surname>Coupe</surname><given-names>AM</given-names></name><name><surname>Lai</surname><given-names>CS</given-names></name><name><surname>Vernes</surname><given-names>SC</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name><name><surname>McKenzie</surname><given-names>F</given-names></name><name><surname>Smith</surname><given-names>RL</given-names></name><name><surname>Monaco</surname><given-names>AP</given-names></name><etal></etal></person-group><article-title>Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits</article-title><source>Am J Hum Genet</source><year>2005</year><volume>76</volume><fpage>1074</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15877281</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeesman</surname><given-names>S</given-names></name><name><surname>Nowaczyk</surname><given-names>MJ</given-names></name><name><surname>Teshima</surname><given-names>I</given-names></name><name><surname>Roberts</surname><given-names>W</given-names></name><name><surname>Cardy</surname><given-names>JO</given-names></name><name><surname>Brian</surname><given-names>J</given-names></name><name><surname>Senman</surname><given-names>L</given-names></name><name><surname>Feuk</surname><given-names>L</given-names></name><name><surname>Osborne</surname><given-names>LR</given-names></name><name><surname>Scherer</surname><given-names>SW</given-names></name></person-group><article-title>Speech and language impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2</article-title><source>Am J Med Genet A</source><year>2006</year><volume>140</volume><fpage>509</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">16470794</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shriberg</surname><given-names>LD</given-names></name><name><surname>Ballard</surname><given-names>KJ</given-names></name><name><surname>Tomblin</surname><given-names>JB</given-names></name><name><surname>Duffy</surname><given-names>JR</given-names></name><name><surname>Odell</surname><given-names>KH</given-names></name><name><surname>Williams</surname><given-names>CA</given-names></name></person-group><article-title>Speech, prosody, and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2</article-title><source>J Speech Lang Hear Res</source><year>2006</year><volume>49</volume><fpage>500</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">16787893</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonkowsky</surname><given-names>JL</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name></person-group><article-title>Molecular cloning and developmental expression of foxP2 in zebrafish</article-title><source>Dev Dyn</source><year>2005</year><volume>234</volume><fpage>740</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16028276</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferland</surname><given-names>RJ</given-names></name><name><surname>Cherry</surname><given-names>TJ</given-names></name><name><surname>Preware</surname><given-names>PO</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Walsh</surname><given-names>CA</given-names></name></person-group><article-title>Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain</article-title><source>J Comp Neurol</source><year>2003</year><volume>460</volume><fpage>266</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">12687690</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haesler</surname><given-names>S</given-names></name><name><surname>Wada</surname><given-names>K</given-names></name><name><surname>Nshdejan</surname><given-names>A</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name><name><surname>Lints</surname><given-names>T</given-names></name><name><surname>Jarvis</surname><given-names>ED</given-names></name><name><surname>Scharff</surname><given-names>C</given-names></name></person-group><article-title>FoxP2 expression in avian vocal learners and non-learners</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>3164</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">15056696</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>CS</given-names></name><name><surname>Gerrelli</surname><given-names>D</given-names></name><name><surname>Monaco</surname><given-names>AP</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Copp</surname><given-names>AJ</given-names></name></person-group><article-title>FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder</article-title><source>Brain</source><year>2003</year><volume>126</volume><fpage>2455</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">12876151</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Medina-Martinez</surname><given-names>O</given-names></name><name><surname>Chu</surname><given-names>LF</given-names></name><name><surname>Samaco</surname><given-names>RC</given-names></name><name><surname>Jamrich</surname><given-names>M</given-names></name></person-group><article-title>Expression of FoxP2 during zebrafish development and in the adult brain</article-title><source>Int J Dev Biol</source><year>2006</year><volume>50</volume><fpage>435</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16525940</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Lu</surname><given-names>MM</given-names></name><name><surname>Morrisey</surname><given-names>EE</given-names></name></person-group><article-title>Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors</article-title><source>J Biol Chem</source><year>2001</year><volume>276</volume><fpage>27488</fpage><lpage>97</lpage><pub-id pub-id-type="pmid">11358962</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>FC</given-names></name><name><surname>Hirokawa</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name></person-group><article-title>Expression of Foxp2, a gene involved in speech and language, in the developing and adult striatum</article-title><source>J Neurosci Res</source><year>2003</year><volume>73</volume><fpage>61</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">12815709</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teramitsu</surname><given-names>I</given-names></name><name><surname>Kudo</surname><given-names>LC</given-names></name><name><surname>London</surname><given-names>SE</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>White</surname><given-names>SA</given-names></name></person-group><article-title>Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>3152</fpage><lpage>63</lpage><pub-id pub-id-type="pmid">15056695</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schon</surname><given-names>C</given-names></name><name><surname>Wochnik</surname><given-names>A</given-names></name><name><surname>Rossner</surname><given-names>A</given-names></name><name><surname>Donow</surname><given-names>C</given-names></name><name><surname>Knochel</surname><given-names>W</given-names></name></person-group><article-title>The FoxP subclass in Xenopus laevis development</article-title><source>Dev Genes Evol</source><year>2006</year><volume>216</volume><fpage>641</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16609867</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itakura</surname><given-names>T</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Kimura</surname><given-names>W</given-names></name><name><surname>Hikosaka</surname><given-names>K</given-names></name><name><surname>Inohaya</surname><given-names>K</given-names></name><name><surname>Kudo</surname><given-names>A</given-names></name><name><surname>Uezato</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>The medaka FoxP2, a homologue of human language gene FOXP2, has a diverged structure and function</article-title><source>J Biochem</source><year>2007</year><pub-id pub-id-type="pmid">18079162</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>W</given-names></name><name><surname>Cho</surname><given-names>JY</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Weisz</surname><given-names>D</given-names></name><name><surname>Elder</surname><given-names>GA</given-names></name><name><surname>Schmeidler</surname><given-names>J</given-names></name><name><surname>De Gasperi</surname><given-names>R</given-names></name><name><surname>Sosa</surname><given-names>MA</given-names></name><name><surname>Rabidou</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>9643</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15983371</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>CA</given-names></name><name><surname>Groszer</surname><given-names>M</given-names></name><name><surname>Preece</surname><given-names>C</given-names></name><name><surname>Coupe</surname><given-names>AM</given-names></name><name><surname>Rajewsky</surname><given-names>K</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name></person-group><article-title>Generation of mice with a conditional Foxp2 null allele</article-title><source>Genesis</source><year>2007</year><volume>45</volume><fpage>440</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17619227</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fujita</surname><given-names>E</given-names></name><name><surname>Tanabe</surname><given-names>Y</given-names></name><name><surname>Shiota</surname><given-names>A</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name><name><surname>Suwa</surname><given-names>K</given-names></name><name><surname>Momoi</surname><given-names>MY</given-names></name><name><surname>Momoi</surname><given-names>T</given-names></name></person-group><article-title>Ultrasonic vocalization impairment of Foxp2 (R552H) knockin mice related to speech-language disorder and abnormality of Purkinje cells</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>3117</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">18287060</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Groszer</surname><given-names>M</given-names></name><name><surname>Keays</surname><given-names>DA</given-names></name><name><surname>Deacon</surname><given-names>RM</given-names></name><name><surname>de Bono</surname><given-names>JP</given-names></name><name><surname>Prasad-Mulcare</surname><given-names>S</given-names></name><name><surname>Gaub</surname><given-names>S</given-names></name><name><surname>Baum</surname><given-names>MG</given-names></name><name><surname>French</surname><given-names>CA</given-names></name><name><surname>Nicod</surname><given-names>J</given-names></name><name><surname>Coventry</surname><given-names>JA</given-names></name><etal></etal></person-group><article-title>Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits</article-title><source>Curr Biol</source><year>2008</year><volume>18</volume><fpage>354</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">18328704</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rochefort</surname><given-names>C</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Scotto-Lomassese</surname><given-names>S</given-names></name><name><surname>Scharff</surname><given-names>C</given-names></name></person-group><article-title>Recruitment of FoxP2-expressing neurons to area X varies during song development</article-title><source>Dev Neurobiol</source><year>2007</year><volume>67</volume><fpage>809</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">17443826</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haesler</surname><given-names>S</given-names></name><name><surname>Rochefort</surname><given-names>C</given-names></name><name><surname>Georgi</surname><given-names>B</given-names></name><name><surname>Licznerski</surname><given-names>P</given-names></name><name><surname>Osten</surname><given-names>P</given-names></name><name><surname>Scharff</surname><given-names>C</given-names></name></person-group><article-title>Incomplete and inaccurate vocal imitation after knockdown of FoxP2 in songbird basal ganglia nucleus Area X</article-title><source>PLoS Biol</source><year>2007</year><volume>5</volume><fpage>e321</fpage><pub-id pub-id-type="pmid">18052609</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Spiteri</surname><given-names>E</given-names></name><name><surname>Konopka</surname><given-names>G</given-names></name><name><surname>Coppola</surname><given-names>G</given-names></name><name><surname>Bomar</surname><given-names>J</given-names></name><name><surname>Oldham</surname><given-names>M</given-names></name><name><surname>Ou</surname><given-names>J</given-names></name><name><surname>Vernes</surname><given-names>SC</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name></person-group><article-title>Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>1144</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17999357</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>SC</given-names></name><name><surname>Spiteri</surname><given-names>E</given-names></name><name><surname>Nicod</surname><given-names>J</given-names></name><name><surname>Groszer</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>JM</given-names></name><name><surname>Davies</surname><given-names>KE</given-names></name><name><surname>Geschwind</surname><given-names>DH</given-names></name><name><surname>Fisher</surname><given-names>SE</given-names></name></person-group><article-title>High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>1232</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">17999362</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hallikas</surname><given-names>O</given-names></name><name><surname>Palin</surname><given-names>K</given-names></name><name><surname>Sinjushina</surname><given-names>N</given-names></name><name><surname>Rautiainen</surname><given-names>R</given-names></name><name><surname>Partanen</surname><given-names>J</given-names></name><name><surname>Ukkonen</surname><given-names>E</given-names></name><name><surname>Taipale</surname><given-names>J</given-names></name></person-group><article-title>Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity</article-title><source>Cell</source><year>2006</year><volume>124</volume><fpage>47</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">16413481</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ciani</surname><given-names>L</given-names></name><name><surname>Salinas</surname><given-names>PC</given-names></name></person-group><article-title>WNTs in the vertebrate nervous system: from patterning to neuronal connectivity</article-title><source>Nat Rev Neurosci</source><year>2005</year><volume>6</volume><fpage>351</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">15832199</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Wu</surname><given-names>SF</given-names></name><name><surname>Goering</surname><given-names>LM</given-names></name><name><surname>Dorsky</surname><given-names>RI</given-names></name></person-group><article-title>Canonical Wnt signaling through Lef1 is required for hypothalamic neurogenesis</article-title><source>Development</source><year>2006</year><volume>133</volume><fpage>4451</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">17050627</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorsky</surname><given-names>RI</given-names></name><name><surname>Itoh</surname><given-names>M</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name><name><surname>Chitnis</surname><given-names>A</given-names></name></person-group><article-title>Two tcf3 genes cooperate to pattern the zebrafish brain</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>1937</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">12642497</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>BT</given-names></name><name><surname>Kwon</surname><given-names>HJ</given-names></name><name><surname>Melton</surname><given-names>C</given-names></name><name><surname>Houghtaling</surname><given-names>P</given-names></name><name><surname>Fritz</surname><given-names>A</given-names></name><name><surname>Riley</surname><given-names>BB</given-names></name></person-group><article-title>Zebrafish msxB, msxC and msxE function together to refine the neural-nonneural border and regulate cranial placodes and neural crest development</article-title><source>Dev Biol</source><year>2006</year><volume>294</volume><fpage>376</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16631154</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JL</given-names></name><name><surname>Bonner</surname><given-names>J</given-names></name><name><surname>Modrell</surname><given-names>M</given-names></name><name><surname>Ragland</surname><given-names>JW</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name><name><surname>Dorsky</surname><given-names>RI</given-names></name><name><surname>Raible</surname><given-names>DW</given-names></name></person-group><article-title>Reiterated Wnt signaling during zebrafish neural crest development</article-title><source>Development</source><year>2004</year><volume>131</volume><fpage>1299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">14973296</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>A</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name><name><surname>Dawid</surname><given-names>IB</given-names></name></person-group><article-title>The homeobox gene mbx is involved in eye and tectum development</article-title><source>Dev Biol</source><year>2002</year><volume>248</volume><fpage>107</fpage><lpage>17</lpage><pub-id pub-id-type="pmid">12142024</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Villefranc</surname><given-names>JA</given-names></name><name><surname>Amigo</surname><given-names>J</given-names></name><name><surname>Lawson</surname><given-names>ND</given-names></name></person-group><article-title>Gateway compatible vectors for analysis of gene function in the zebrafish</article-title><source>Dev Dyn</source><year>2007</year><volume>236</volume><fpage>3077</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">17948311</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan</surname><given-names>KM</given-names></name><name><surname>Fujimoto</surname><given-names>E</given-names></name><name><surname>Grabher</surname><given-names>C</given-names></name><name><surname>Mangum</surname><given-names>BD</given-names></name><name><surname>Hardy</surname><given-names>ME</given-names></name><name><surname>Campbell</surname><given-names>DS</given-names></name><name><surname>Parant</surname><given-names>JM</given-names></name><name><surname>Yost</surname><given-names>HJ</given-names></name><name><surname>Kanki</surname><given-names>JP</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name></person-group><article-title>The Tol2kit: A multisite gateway-based construction kit for Tol2 transposon transgenesis constructs</article-title><source>Dev Dyn</source><year>2007</year><volume>236</volume><fpage>3088</fpage><lpage>3099</lpage><pub-id pub-id-type="pmid">17937395</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K</given-names></name></person-group><article-title>Transgenesis and gene trap methods in zebrafish by using the Tol2 transposable element</article-title><source>Methods Cell Biol</source><year>2004</year><volume>77</volume><fpage>201</fpage><lpage>22</lpage><pub-id pub-id-type="pmid">15602913</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HC</given-names></name><name><surname>Kim</surname><given-names>CH</given-names></name><name><surname>Bae</surname><given-names>YK</given-names></name><name><surname>Yeo</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Hong</surname><given-names>SK</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Yoo</surname><given-names>KW</given-names></name><name><surname>Hibi</surname><given-names>M</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name><etal></etal></person-group><article-title>Analysis of upstream elements in the HuC promoter leads to the establishment of transgenic zebrafish with fluorescent neurons</article-title><source>Dev Biol</source><year>2000</year><volume>227</volume><fpage>279</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">11071755</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Picker</surname><given-names>A</given-names></name><name><surname>Scholpp</surname><given-names>S</given-names></name><name><surname>Bohli</surname><given-names>H</given-names></name><name><surname>Takeda</surname><given-names>H</given-names></name><name><surname>Brand</surname><given-names>M</given-names></name></person-group><article-title>A novel positive transcriptional feedback loop in midbrain-hindbrain boundary development is revealed through analysis of the zebrafish pax2.1 promoter in transgenic lines</article-title><source>Development</source><year>2002</year><volume>129</volume><fpage>3227</fpage><lpage>39</lpage><pub-id pub-id-type="pmid">12070097</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Del Bene</surname><given-names>F</given-names></name><name><surname>Ettwiller</surname><given-names>L</given-names></name><name><surname>Skowronska-Krawczyk</surname><given-names>D</given-names></name><name><surname>Baier</surname><given-names>H</given-names></name><name><surname>Matter</surname><given-names>JM</given-names></name><name><surname>Birney</surname><given-names>E</given-names></name><name><surname>Wittbrodt</surname><given-names>J</given-names></name></person-group><article-title>In vivo validation of a computationally predicted conserved Ath5 target gene set</article-title><source>PLoS Genet</source><year>2007</year><volume>3</volume><fpage>1661</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">17892326</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liegeois</surname><given-names>F</given-names></name><name><surname>Baldeweg</surname><given-names>T</given-names></name><name><surname>Connelly</surname><given-names>A</given-names></name><name><surname>Gadian</surname><given-names>DG</given-names></name><name><surname>Mishkin</surname><given-names>M</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name></person-group><article-title>Language fMRI abnormalities associated with FOXP2 gene mutation</article-title><source>Nat Neurosci</source><year>2003</year><volume>6</volume><fpage>1230</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14555953</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Belton</surname><given-names>E</given-names></name><name><surname>Salmond</surname><given-names>CH</given-names></name><name><surname>Watkins</surname><given-names>KE</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name><name><surname>Gadian</surname><given-names>DG</given-names></name></person-group><article-title>Bilateral brain abnormalities associated with dominantly inherited verbal and orofacial dyspraxia</article-title><source>Hum Brain Mapp</source><year>2003</year><volume>18</volume><fpage>194</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">12599277</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alcock</surname><given-names>KJ</given-names></name><name><surname>Passingham</surname><given-names>RE</given-names></name><name><surname>Watkins</surname><given-names>KE</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name></person-group><article-title>Oral dyspraxia in inherited speech and language impairment and acquired dysphasia</article-title><source>Brain Lang</source><year>2000</year><volume>75</volume><fpage>17</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">11023636</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ackermann</surname><given-names>H</given-names></name></person-group><article-title>Cerebellar contributions to speech production and speech perception: psycholinguistic and neurobiological perspectives</article-title><source>Trends Neurosci</source><year>2008</year><volume>31</volume><fpage>265</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">18471906</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name><name><surname>Gadian</surname><given-names>DG</given-names></name><name><surname>Copp</surname><given-names>A</given-names></name><name><surname>Mishkin</surname><given-names>M</given-names></name></person-group><article-title>FOXP2 and the neuroanatomy of speech and language</article-title><source>Nat Rev Neurosci</source><year>2005</year><volume>6</volume><fpage>131</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15685218</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vargha-Khadem</surname><given-names>F</given-names></name><name><surname>Watkins</surname><given-names>K</given-names></name><name><surname>Alcock</surname><given-names>K</given-names></name><name><surname>Fletcher</surname><given-names>P</given-names></name><name><surname>Passingham</surname><given-names>R</given-names></name></person-group><article-title>Praxic and nonverbal cognitive deficits in a large family with a genetically transmitted speech and language disorder</article-title><source>Proc Natl Acad Sci USA</source><year>1995</year><volume>92</volume><fpage>930</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7846081</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Galceran</surname><given-names>J</given-names></name><name><surname>Miyashita-Lin</surname><given-names>EM</given-names></name><name><surname>Devaney</surname><given-names>E</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><name><surname>Grosschedl</surname><given-names>R</given-names></name></person-group><article-title>Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>469</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">10631168</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nyholm</surname><given-names>MK</given-names></name><name><surname>Wu</surname><given-names>SF</given-names></name><name><surname>Dorsky</surname><given-names>RI</given-names></name><name><surname>Grinblat</surname><given-names>Y</given-names></name></person-group><article-title>The zebrafish zic2a-zic5 gene pair acts downstream of canonical Wnt signaling to control cell proliferation in the developing tectum</article-title><source>Development</source><year>2007</year><volume>134</volume><fpage>735</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">17215296</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kimmel</surname><given-names>CB</given-names></name><name><surname>Ballard</surname><given-names>WW</given-names></name><name><surname>Kimmel</surname><given-names>SR</given-names></name><name><surname>Ullmann</surname><given-names>B</given-names></name><name><surname>Schilling</surname><given-names>TF</given-names></name></person-group><article-title>Stages of embryonic development of the zebrafish</article-title><source>Dev Dyn</source><year>1995</year><volume>203</volume><fpage>253</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">8589427</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dorsky</surname><given-names>RI</given-names></name><name><surname>Sheldahl</surname><given-names>LC</given-names></name><name><surname>Moon</surname><given-names>RT</given-names></name></person-group><article-title>A transgenic Lef1/beta-catenin-dependent reporter is expressed in spatially restricted domains throughout zebrafish development</article-title><source>Dev Biol</source><year>2002</year><volume>241</volume><fpage>229</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">11784107</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Denkers</surname><given-names>N</given-names></name><name><surname>Garcia-Villalba</surname><given-names>P</given-names></name><name><surname>Rodesch</surname><given-names>CK</given-names></name><name><surname>Nielson</surname><given-names>KR</given-names></name><name><surname>Mauch</surname><given-names>TJ</given-names></name></person-group><article-title>FISHing for chick genes: Triple-label whole-mount fluorescence in situ hybridization detects simultaneous and overlapping gene expression in avian embryos</article-title><source>Dev Dyn</source><year>2004</year><volume>229</volume><fpage>651</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14991720</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>S</given-names></name><name><surname>Grice</surname><given-names>EA</given-names></name><name><surname>Vinton</surname><given-names>RM</given-names></name><name><surname>Bessling</surname><given-names>SL</given-names></name><name><surname>Urasaki</surname><given-names>A</given-names></name><name><surname>Kawakami</surname><given-names>K</given-names></name><name><surname>McCallion</surname><given-names>AS</given-names></name></person-group><article-title>Evaluating the biological relevance of putative enhancers using Tol2 transposon-mediated transgenesis in zebrafish</article-title><source>Nat Protoc</source><year>2006</year><volume>1</volume><fpage>1297</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">17406414</pub-id></citation></ref><ref id="B50"><citation citation-type="other"><person-group person-group-type="author"><name><surname>Bonner</surname><given-names>J</given-names></name><name><surname>Gribble</surname><given-names>SL</given-names></name><name><surname>Veien</surname><given-names>ES</given-names></name><name><surname>Nikoaus</surname><given-names>OB</given-names></name><name><surname>Weidinger</surname><given-names>G</given-names></name><name><surname>Dorsky</surname><given-names>RI</given-names></name></person-group><article-title>Distinct pathways mediate patterning and proliferation in the dorsal spinal cord downstream of canonical Wnt signaling</article-title><source>Dev Biol</source><comment></comment></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bonner</surname><given-names>J</given-names></name><name><surname>Gribble</surname><given-names>SL</given-names></name><name><surname>Veien</surname><given-names>ES</given-names></name><name><surname>Nikolaus</surname><given-names>OB</given-names></name><name><surname>Weidinger</surname><given-names>G</given-names></name><name><surname>Dorsky</surname><given-names>RI</given-names></name></person-group><article-title>Proliferation and patterning are mediated independently in the dorsal spinal cord downstream of canonical Wnt signaling</article-title><source>Dev Biol</source><year>2008</year><volume>313</volume><fpage>398</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">18062957</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suli</surname><given-names>A</given-names></name><name><surname>Mortimer</surname><given-names>N</given-names></name><name><surname>Shepherd</surname><given-names>I</given-names></name><name><surname>Chien</surname><given-names>CB</given-names></name></person-group><article-title>Netrin/DCC signaling controls contralateral dendrites of octavolateralis efferent neurons</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>13328</fpage><lpage>37</lpage><pub-id pub-id-type="pmid">17182783</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname><given-names>LA</given-names></name><name><surname>McCutchen</surname><given-names>MD</given-names></name><name><surname>Bonner-Fraser</surname><given-names>M</given-names></name><name><surname>Fraser</surname><given-names>SE</given-names></name><name><surname>Bumm</surname><given-names>LA</given-names></name><name><surname>McCauley</surname><given-names>DW</given-names></name></person-group><article-title>Fluorescent in situ hybridization employing the conventional NBT/BCIP chromogenic stain</article-title><source>BioTechniques</source><year>2007</year><volume>42</volume><fpage>756</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">17612300</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karolchik</surname><given-names>D</given-names></name><name><surname>Baertsch</surname><given-names>R</given-names></name><name><surname>Diekhans</surname><given-names>M</given-names></name><name><surname>Furey</surname><given-names>TS</given-names></name><name><surname>Hinrichs</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>YT</given-names></name><name><surname>Roskin</surname><given-names>KM</given-names></name><name><surname>Schwartz</surname><given-names>M</given-names></name><name><surname>Sugnet</surname><given-names>CW</given-names></name><name><surname>Thomas</surname><given-names>DJ</given-names></name><etal></etal></person-group><article-title>The UCSC Genome Browser Database</article-title><source>Nucleic Acids Res</source><year>2003</year><volume>31</volume><fpage>51</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">12519945</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinmann</surname><given-names>AS</given-names></name><name><surname>Bartley</surname><given-names>SM</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Farnham</surname><given-names>PJ</given-names></name></person-group><article-title>Use of chromatin immunoprecipitation to clone novel E2F target promoters</article-title><source>Mol Cell Biol</source><year>2001</year><volume>21</volume><fpage>6820</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">11564866</pub-id></citation></ref></ref-list></back></article> 